Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
A structural and functional analysis of Nna1 in Purkinje cell degeneration (pcd) mice.
[canavan disease]
The
axotomy-inducible
enzyme
Nna
1
defines
a
subfamily
of
M
14
metallocarboxypeptidases
,
and
its
mutation
underlies
the
Purkinje
cell
degeneration
(
pcd
)
mouse
.
However
,
the
relationship
among
its
catalytic
activity
,
substrate
specificities
,
and
the
critical
processes
of
neurodegeneration
/
axon
regeneration
is
incompletely
understood
.
Here
we
used
a
transgenic
rescue
strategy
targeting
expression
of
modified
forms
of
Nna
1
to
Purkinje
cells
in
pcd
mice
to
determine
structure-activity
relationships
for
neuronal
survival
and
in
parallel
characterized
the
enzymatic
properties
of
purified
recombinant
Nna
1
.
The
Nna
1
subfamily
uniquely
shares
conserved
substrate-determining
residues
with
aspartoacylase
that
,
when
mutated
,
cause
Canavan
disease
.
Homologous
mutations
(
D
1007
E
and
R
1078
E
)
inactivate
Nna
1
in
vivo
,
as
does
mutation
of
its
catalytic
glutamate
(
E
1094
A
)
,
which
implies
that
metabolism
of
acidic
substrates
is
essential
for
neuronal
survival
.
Consistent
with
reports
that
Nna
1
is
a
tubulin
glutamylase
,
recombinant
Nna
1
-
but
not
the
catalytic
mutants-removes
glutamate
from
tubulin
.
Recombinant
Nna
1
metabolizes
synthetic
substrates
with
2
or
more
C-
terminal
glutamate
(
but
not
aspartate
)
residues
(
V
(
max
)
for
3
glutamates
is
∼
7
-
fold
higher
than
2
glutamates
although
K
(
M
)
is
similar
)
.
Catalysis
is
not
ATP
/
GTP
dependent
,
and
mutating
the
ATP
/
GTP
binding
site
of
Nna
1
has
no
effect
in
vivo
.
Nna
1
is
a
monomeric
enzyme
essential
for
neuronal
survival
through
hydrolysis
of
polyglutamate-containing
substrates
.
Diseases
Validation
Diseases presenting
"in parallel characterized the enzymatic properties of purified recombinant nna1"
symptom
canavan disease
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom